Active Pharmaceutical Ingredients (API) Global Market Report 2022: Sustained Increase in Drug R&D Spending to Drive Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (API) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Active Pharmaceutical Ingredients (API) Market to Reach $264.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Active Pharmaceutical Ingredients (API) estimated at US$176.1 Billion in the year 2020, is projected to reach a revised size of US$264.1 Billion by 2027, growing at a CAGR of 6% over the period 2020-2027. Innovative, one of the segments analyzed in the report, is projected to record 5.7% CAGR and reach US$180.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Generic segment is readjusted to a revised 6.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $61 Billion, While China is Forecast to Grow at 6.2% CAGR

The Active Pharmaceutical Ingredients (API) market in the U.S. is estimated at US$61 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$42 Billion by the year 2027 trailing a CAGR of 6.2% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 5.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Select Competitors (Total 266 Featured)

• AbbVie Inc.
• Aurobindo Pharma Ltd.
• BASF SE
• Boehringer Ingelheim International GmbH
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• Lupin Ltd.
• Merck KGaA
• Novartis International AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Sustained Increase in Drug R&D Spending to Drive API Market
• Increased API Sourcing Creates the need for More Scrutiny of Suppliers for Best Quality Products
• Preference for Specialized CDMO Contractors on the Rise
• Strong Rise in Pharmaceutical Sales to Drive Demand
• The AIC Approach for Faster Assessment of Viable Drug Candidates
• Drug Makers Embrace Digital Technology Amidst COVID-19 Crisis
• Demand for HPAPIs on the Rise
• AI Finds Growing Application in Drug Discovery and Development
• Microdosing Beneficial for the Formulation of High Potency Ingredients
• Growing Penetration of Generic Drugs Augments Market Prospects
• Increasing Interest in Biopharmaceuticals Supports Market Demand
• Rising Number of Biologics Approvals Augurs Well
• Growing Biosimilars Market Create Opportunities for APIs
• Growing Attention Towards Personalized Medicine Spurs Demand for Complex API
• Increasing Sales of OTC Drugs Presents an Opportunity for APIs
• Growing Prevalence of Infectious Diseases to Spur Growth
• Rising Incidence of Cancer & Need to Reduce Cancer-Related Mortality Spell Increased Demand
• Increasing Prevalence of Chronic Disorders Fuels Market Growth
• Rising Incidence of Cardiovascular Diseases Revs Up Opportunities
• Upsurge in ANDA Approvals Bodes Well
• Aging Population & Increasing Burden of Chronic Diseases Spurs Pharma Product Sales, Driving Market Growth
• Novel Technology for Continuous Manufacturing of APIs

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 266

For more information about this report visit https://www.researchandmarkets.com/r/i199qu